retatrutide safety trial results Phase 3 Results: Trials, Safety, and NHS Outlook – Bolt Pharmacy Triple hormone receptor agonist retatrutide

GLP-1 medications are named after glucagon-like peptide-1, a natural hormone that reduces appetite, slows digestion, and boosts insulin release

The gradual escalation serves two purposes: it allows the body to adapt to GLP-1 receptor activation (reducing nausea), and it permits glucagon receptor effects to build progressively without overwhelming metabolic pathways

You can be in very good health and have excess weight, she says

Decaffeinated green tea catechins + chlorogenic acids Included to enhance post-meal GLP-1 response and support insulin sensitivity, especially after higher-calorie meals

A 12-week trial period is the minimum needed to evaluate whether it works for you